SCHEMBL3344599

SCHEMBL3344599

Cc1ccc(-n2cnnc2)cc1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.51
MEN1 O00255 6/20 0.51
MAPT P10636 4/20 0.51
KDM4E B2RXH2 3/20 0.51
NPSR1 Q6W5P4 1/20 0.51
ALDH1A1 P00352 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
CASP1 P29466 1/20 0.46
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP3A4 P08684 4/20 0.43
NPC1 O15118 5/20 0.41
RAB9A P51151 4/20 0.41
GAA P10253 2/20 0.41
HPGD P15428 1/20 0.41
MCL1 Q07820 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
TSHR P16473 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7314884 0.86 KDM4E (0.50) KMT2AMEN1MAPTKDM4ENPSR1
SCHEMBL12841361 0.83 CYP1A2 (0.47) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL3343040 0.80 NR2E1 (0.48) KMT2AMEN1MAPTKDM4ENPSR1
SCHEMBL654342 0.79 MAPT (0.50) KMT2AMEN1MAPTKDM4ENPSR1
SCHEMBL10053481 0.78 PKM (0.48) KMT2AMEN1MAPTALDH1A1CYP1A2
SCHEMBL941849 0.75 CYP2C9 (0.53) KMT2AMEN1MAPTALDH1A1CYP1A2
SCHEMBL10022383 0.75 CYP1A2 (0.40) KMT2AMEN1CYP1A2CYP2C9CYP3A4
SCHEMBL3344595 0.74 L3MBTL1 (0.47) KMT2AMEN1KDM4EALDH1A1TDP1
SCHEMBL8431847 0.73 CYP1A2 (0.38) KMT2AMEN1MAPTCYP1A2CYP2C9
SCHEMBL10053600 0.73 L3MBTL1 (0.49) KMT2AMEN1KDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 KMT2A 3250/4885MEN1 2632/4885MAPT 2598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.